Teresa L. Kline serves as Executive at Intersect ENT, Inc., where they oversee executive responsibilities. Since joining the company, Teresa L. Kline has executed 17 insider transactions totaling $142.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 14, 2025 involved selling 9,818 shares valued at $0.
Teresa L. Kline currently holds 25,211 shares of Intersect ENT, Inc. (XENT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Teresa L. Kline has been a net buyer of XENT stock. They have purchased $142.6K and sold $0 worth of shares.
Teresa L. Kline's most recent insider trade was on Aug 14, 2025, when they sold 9,818 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 3, 2024 | AMED | $0 | Award | 1,678 | $N/A | Discretionary |
| May 12, 2023 | OMI | $0 | Award | 9,344 | $N/A | Discretionary |
| May 3, 2023 | AMED | $0 | Award | 1,941 | $N/A | Discretionary |
| Jun 9, 2022 | AMED | $0 | Award | 1,304 | $N/A | Discretionary |
| Jun 1, 2022 | OMI | $0 | Award | 4,713 | $N/A | Discretionary |
| May 13, 2022 | XENT | $249.6K | Tender | 8,837 | $28.25 | Discretionary |
| May 13, 2022 | XENT | $91.5K | Tender | 3,239 | $28.25 | Discretionary |
| Jun 8, 2021 | AMED | $0 | Award | 574 | $N/A | Discretionary |
| Jun 3, 2021 | XENT | $0 | Award | 3,239 | $N/A | Discretionary |
| Jun 9, 2020 | AMED | $0 | Award | 851 | $N/A | Discretionary |
| Jun 4, 2020 | XENT | $0 | Award | 5,011 | $N/A | Discretionary |
| Mar 16, 2020 | AMED | $142.6K | Purchase | 1,000 | $142.63 | Discretionary |
| Nov 22, 2019 | AMED | $0 | Award | 780 | $N/A | Discretionary |
| Jun 4, 2019 | XENT | $0 | Award | 2,312 | $N/A | Discretionary |
| Jun 5, 2018 | XENT | $0 | Award | 1,514 | $N/A | Discretionary |